Biomedica Immunoassays started its own R&D program in 1988, and is now producing a range of innovative immunoassays for cardiovascular investigations and bone metabolism.
A worldwide distribution network has been established for these lines.


Key Products

• Bone Regulation
  • Sclerostin ELISA
  • DKK-1 ELISA
  • Osteoprotegerin ELISA
  • Free sRANKL ELISA
• Cardiovascular Diseases
  • Endothelin ELISA
  • Big Endothelin ELISA
  • proANP ELISA
  • BNP Fragment EIA
  • NT-proBNP ELISA
  • NT-proCNP ELISA
• Infectious Diseases
  • Borrelia lgG ELISA
  • Borrelia lgM ELISA
  • Rheumatoid factor stripper
  • Oxidative Stress and Atherosclerosis
  • Anti-oxidized LDL (oLAB) ELISA
  • OxyStat Assay (Peroxides)
  • Oxidized LDL ELISA
• Various
  • EZ4U cell proliferation assay
  • Anti C4d
  • Anti C4d, Fitc
• Analytical Testing Services
  
  • ELISA – diagnostic analysis of soluble biomarkers in biological fluids is offered for all Biomedica Immunoassay ELISAs
  • Luminex – simultaneous quantitative analysis of multiple biomarkers on the Luminex platform according to the customers specifications
  • osteomiR - microRNA analysis for the measurement of bone density in osteoporosis and type 2 diabetes patients
  • thrombomiR - microRNA analysis for the measurement of cardiovascular risk fatcors
  • LecChip – analysis of O- and N-glycans on proteins

 Link to Biomedica